Skip to content
Friday, February 27, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • JD Vance praises Tucker Carlson-Mike Huckabee interview as ‘a really good conversation’ February 27, 2026
  • Amid Iran tensions, Huckabee tells US embassy staff in Israel they should leave ‘TODAY’ if they wish February 27, 2026
  • By Your Command – A poem for Parsha Tetzaveh February 26, 2026
  • As a YouTuber targets Orthodox communities, the right wrestles with its antisemitism problem February 26, 2026
  • San Francisco mayor Daniel Lurie condemns ‘Tax the Jews’ chant heard during protest February 26, 2026
  • HarperCollins to publish book of conversations with Rabbi Eli Schlanger, Chabad emissary slain in Sydney February 26, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.